Cytokine storm in Chikungunya: Can we call it multisystem inflammatory syndrome associated with Chikungunya?
COVID-19
Chikungunya
Cytokine storm
Multisystem inflammatory syndrome
SARS-CoV-2
Síndrome inflamatorio multisistémico
Tormenta de citoquinas
Journal
Reumatologia clinica
ISSN: 2173-5743
Titre abrégé: Reumatol Clin (Engl Ed)
Pays: Spain
ID NLM: 101717526
Informations de publication
Date de publication:
Apr 2024
Apr 2024
Historique:
received:
07
05
2023
revised:
18
09
2023
accepted:
16
10
2023
medline:
22
4
2024
pubmed:
22
4
2024
entrez:
21
4
2024
Statut:
ppublish
Résumé
Paraguay is currently facing a new outbreak of Chikungunya virus. This report summarizes two severe cases of Chikungunya (CHIKV) infection, confirmed by real-time reverse transcription polymerase chain reaction. We present the cases of patients with acute CHIKV infection and multisystem involvement, with fever, rash, abdominal pain, vomiting, myocarditis, and coronary artery anomalies, very similar to the cases described in MIS-C related to SARS-CoV-2 during the COVID-19 Pandemic. Both patients received IVIG and methylprednisolone, with good clinical response. In this setting of cytokine storm in Chikungunya, can we call it "Multisystem inflammatory syndrome associated with Chikungunya"?.
Identifiants
pubmed: 38644032
pii: S2173-5743(24)00052-2
doi: 10.1016/j.reumae.2024.04.005
pii:
doi:
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
223-225Informations de copyright
Copyright © 2023 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.